Korea Bio-Gen Co.Ltd Total Liabilities

Latest as of June 2026: ₩6.11 Billion KRW ≈ $4.14 Million USD

Korea Bio-Gen Co.Ltd total liabilities. Based on the latest financial reports, Korea Bio-Gen Co.Ltd (318000) has total liabilities worth ₩6.11 Billion KRW (≈ $4.14 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Korea Bio-Gen Co.Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Korea Bio-Gen Co.Ltd (2017–2025)

Total liabilities of Korea Bio-Gen Co.Ltd from 2017 to 2025. This chart illustrates how Korea Bio-Gen Co.Ltd's total liabilities have evolved over time, based on quarterly financial data.

Korea Bio-Gen Co.Ltd Competitors by Total Liabilities

The table below lists competitors of Korea Bio-Gen Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
All In! Games S.A. WAR:ALG	Poland	zł26.57 Million
LOOP INDUSTRIES DL-001 F:3L9	Germany	€18.72 Million
Minox International Group Berhad KLSE:0288	Malaysia	RM24.10 Million
Seremban Engineering Bhd KLSE:5163	Malaysia	RM126.30 Million
Ahmad Zaki Resources Bhd KLSE:7078	Malaysia	RM4.51 Billion
YKGI Holdings Bhd KLSE:7020	Malaysia	RM153.59 Million
Waja Konsortium Bhd KLSE:0102	Malaysia	RM18.17 Million
NexturnBioscience Co. Ltd KQ:089140	Korea	₩128.65 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Korea Bio-Gen Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Korea Bio-Gen Co.Ltd asset portfolio.

Liquidity & Leverage Metrics

Korea Bio-Gen Co.Ltd Total Liabilities Ratios Explained

Korea Bio-Gen Co.Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	6.52	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.13	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.12	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Korea Bio-Gen Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Korea Bio-Gen Co.Ltd (2017–2025)

The table below shows the annual total liabilities of Korea Bio-Gen Co.Ltd from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩5.42 Billion ≈ $3.67 Million	-19.39%
2024-12-31	₩6.73 Billion ≈ $4.56 Million	+72.56%
2023-12-31	₩3.90 Billion ≈ $2.64 Million	-52.04%
2022-12-31	₩8.13 Billion ≈ $5.51 Million	-21.76%
2021-12-31	₩10.39 Billion ≈ $7.04 Million	+257.63%
2020-12-31	₩2.91 Billion ≈ $1.97 Million	+17.54%
2019-12-31	₩2.47 Billion ≈ $1.67 Million	-72.00%
2018-12-31	₩8.83 Billion ≈ $5.98 Million	+12.08%
2017-12-31	₩7.88 Billion ≈ $5.34 Million	--

About Korea Bio-Gen Co.Ltd

KQ:318000 Korea Specialty Chemicals

Market Cap

$14.00 Million

₩20.66 Billion KRW

Market Cap Rank

#26029 Global

#1940 in Korea

Share Price

₩2375.00

Change (1 day)

-1.66%

52-Week Range

₩2375.00 - ₩5160.00

All Time High

₩19197.91